Experienced in Narcolepsy

Dr. John E. Trusheim

Neurology
Noran Neurological Clinic, P.A.
3601 Minnesota Dr, Suite 200, 
Bloomington, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Narcolepsy
Noran Neurological Clinic, P.A.
3601 Minnesota Dr, Suite 200, 
Bloomington, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Trusheim is a Neurologist in Bloomington, Minnesota. Dr. Trusheim is rated as an Experienced provider by MediFind in the treatment of Narcolepsy. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Trusheim is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MN
Hospital Affiliations
Northfield Hospital
Allina Health Faribault Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Sunshine Health
  • EPO
  • HMO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

NORAN NEUROLOGICAL CLINIC, P.A.
3601 Minnesota Dr, Suite 200, Bloomington, MN 55435

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: September 09, 2025
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

5 Total Publications

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Journal: JAMA oncology
Published: November 17, 2022
Similar Doctors
Distinguished in Narcolepsy
Dr. John A. Damergis
Sleep Medicine | Neurology
Distinguished in Narcolepsy
Dr. John A. Damergis
Sleep Medicine | Neurology

Noran Neurological Clinic, P.A.

2828 Chicago Ave, Suite 200, 
Minneapolis, MN 
 (7.0 miles away)
612-879-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Damergis is a Sleep Medicine specialist and a Neurologist in Minneapolis, Minnesota. Dr. Damergis is rated as a Distinguished provider by MediFind in the treatment of Narcolepsy. His top areas of expertise are Insomnia, REM Behavior Disorder, Idiopathic Hypersomnia, and Narcolepsy. Dr. Damergis is currently accepting new patients.

Distinguished in Narcolepsy
Dr. Erin C. Golden
Sleep Medicine | Neurology
Distinguished in Narcolepsy
Dr. Erin C. Golden
Sleep Medicine | Neurology

Hennepin Healthcare System Inc

701 Park Ave, 
Minneapolis, MN 
 (8.3 miles away)
612-873-6963
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Erin Golden is a Sleep Medicine specialist and a Neurologist in Minneapolis, Minnesota. Dr. Golden is rated as an Advanced provider by MediFind in the treatment of Narcolepsy. Her top areas of expertise are REM Behavior Disorder, Insomnia, Obstructive Sleep Apnea, and Narcolepsy. Dr. Golden is currently accepting new patients.

Advanced in Narcolepsy
Laura Meyer, NP
Nurse Practitioner | Neurology
Advanced in Narcolepsy
Laura Meyer, NP
Nurse Practitioner | Neurology

Mankato Clinic Main Street

1230 East Main Street, 2nd Floor, 
Mankato, MN 
 (60.0 miles away)
507-389-8568
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Laura Meyer is a Neurologist and a Nurse Practitioner in Mankato, Minnesota. Ms. Meyer is rated as an Advanced provider by MediFind in the treatment of Narcolepsy. Her top areas of expertise are Periodic Limb Movement Disorder, Epilepsy, Migraine, and Restless Legs Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Trusheim's expertise for a condition
ConditionClose
    View All 16 Distinguished Conditions
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile